Safety and Feasibility of Remote Ischemic Conditioning on Prehypertension and Early-stage Hypertension

Prehypertension Clinical Trial

Official title:

Safety and Feasibility of Remote Ischemic Conditioning on Prehypertension and Early-Stage Hypertension

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04254432
• Other study ID #: RIC-HP-1
• Status: Recruiting
• Phase: Phase 1/Phase 2
• Start date: June 30, 2019
• Est. completion date: March 30, 2020

Study information

• Verified date: February 2020
• Source: Capital Medical University
• Contact: yu gao
• Phone: 8613051119757
• Email: yingmudao1990[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Nowadays, the incidence of stroke in China has reached 1.6‰, and this disease has become a primary cause of death in China. One of its major risk factors is hypertension. As shown in the researches, the risk of stroke grows remarkably when the blood pressure increases and there exists a log-linear relationship between them. Systolic pressure and diastolic pressure relate to the risk of stroke independently. Systolic pressure decreasing 10mmHg will reduce the stroke risk by 31% and a decrease of 1~3mmHg will reduce the stroke risk by20~30%. As to diastolic pressure, a 5mmHg decrease will reduce the stroke risk by 34% and a 10mmHg decrease will reduce the stroke risk by 56%.In addition, patients with isolated systolic hypertension (SPB≥160mmHg, DPB≤90mmHg) or critical isolated systolic hypertension (SPB=140~159mmHg, DPB< 90mmHg) will suffer a higher risk of stroke than people with normal blood pressure. The ACC has already revised its Hypertension ManagementGuidelines of the standard of diagnosis for hypertension and the timing of starting medical treatment in hypertensive patients. Because more and more researches shown that people with blood pressure between 120-139/80-89mmHg have higher risk of ASCVSD compared to those with blood pressure lower than120/80mmHg; However, in China, the diagnostic criteria for hypertension has not been revised yet. Therefore, we still have a blind spot in treating such patients who suffer from borderline systolic hypertension at 130~140 mmHg of blood-pressure with or without ASCVD or those with the first stage hypertension but refusing to take anti-hypertension drugs. What is more, most of them are middle-aged adults, once they have a stroke, it would lead to terrible and costly consequences to both their family and society. Thus, it is necessary to explore new non-pharmacological methods to control blood pressure for reducing the risk of stroke

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: March 30, 2020
• Est. primary completion date: January 2, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• systolic blood pressure between 160 and 125 mmHg or diastolic blood pressure between 80 and 100 mmHg

• age=18

• essential hypertension

• patient did not take anti-hypertensive medicine regularly

Exclusion Criteria:

• patients with severe uncontrolled diabetes

• contraindication for remote ischemic preconditioning

• life expectancy less than 1 year

• patients with atrial fibrillation or other kind of arrhythmia

• unwilling to be followed up or poor compliance.

Related Conditions & MeSH terms

• Early Stage Hypertension
• Hypertension
• Ischemia
• Prehypertension
• Remote Ischemic Conditioning

Intervention

Device:
• remote ischemic conditioning
RIC is a physical strategy performed by an electric auto-control device with cuffs placed on unilateral arms and inflated to 200 mmHg for 5-min followed by deflation for 5-min, the procedures are performed repeatedly for 5 times# two times per day. The duration of the treatment is 4 weeks.

Locations

Country	Name	City	State
China	Xuanwu Hospital, Capital Medical University	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Capital Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	clinical efficacy of remote ischemic conditioning on hyperetension	the systolic blood pressure and diastolic blood pressure before and after the treatment would be recorded. the defference between baseline BP and that after treatment would be used to measure efficacy.	4 weeks
Primary	tolerability and feasibility of remote ischemic conditioning on hypertension	there are 56 treatments in totall during 4weeks, the percentage of the completement of each treatment would be used to mearure the tolerance.	4 weeks
Secondary	safety of remote ischemic conditioning on hypertension	all the adverse effect would be recorded and the percetage of adverse effect happened in the group would be used to measure the safety.	4 weeks